Health

Advisory

AVIAN INFLUENZA A (H5N1)

The Centers for Disease Control and Prevention (CDC) has alerted state health agencies of increasing concerns regarding human

transmission of avian influenza following the report of three human deaths from confirmed avian influenza H5 infection in Vietnam. The

Delaware Division of Public Health (DPH) is providing this Health Advisory to assure that Delaware health care providers are aware of the

emerging threat.

While there is no evidence of avian influenza in humans or birds in Delaware at this time, DPH is enhancing our surveillance activities:

• Active syndromic surveillance – In response to Severe Acute Respiratory Syndrome (SARS) and general concerns about bioterrorism,Delaware hospitals are already reporting daily the number of patients treated for specific symptoms. This system was established several

  years ago, and includes symptoms consistent with human avian influenza. Significant increases in the number of patients with such

  symptoms are investigated by DPH epidemiologists.

• Enhanced influenza surveillance – Health care providers in Delaware are requested to review the guidance from CDC below and reportsuspect cases to DPH immediately. Such reports, as well as requests to arrange laboratory testing, can be made by calling the telephone

  immediately below.

• Sentinel influenza surveillance – DPH is seeking to expand its network of participants in the sentinel influenza surveillanceprogram. Currently, four physician-practices submit nasopharyngeal swabs from patients with influenza-like symptoms to the DPH laboratory

  for viral testing. Influenza, when identified, is typed by the DPH laboratory. The DPH laboratory analysis is provided at no cost to the

  physician and patient. Physician-practices interested in participating in this program, especially from New Castle and Sussex Counties,

  should contact Dr. Leroy Hathcock, State Epidemiologist at (302) 744-4703 or via email at:  leroy.hathcock@delaware.gov for

  further information.

Questions about this Health Advisory, requests for laboratory testing and reports of suspected cases can be directed to DPH at

1-888-295-5156. This number is operational all the time. During non-business hours, it is available for emergencies.

This is an official

CDC Health Update

Update on Avian Influenza A (H5N1)

This update reviews the current situation and the surveillance and diagnostic recommendations for avian influenza A (H5N1). The

recommendations for avian influenza A (H5N1) remain at the enhanced level established in February 2004. As detailed in the

recommendations below, vigilance in the clinical setting for avian influenza (H5N1) requires that health-care providers consistently

obtain international travel and other exposure risk information for persons who have specified respiratory symptoms.

Current Situation

On August 12, 2004, the Vietnamese Ministry of Health officially reported to the World Health Organization (WHO) (see: http://www.who.int/csr/don/2004_08_12/en/ ) three human deaths from confirmed avian

influenza H5 infection. Additional tests are needed to determine whether the virus belongs to the same H5N1 strain that caused 22 cases

(15 deaths) in Vietnam and 12 cases (8 deaths) in Thailand earlier this year.

Cambodia, China, Indonesia, Japan, Laos, South Korea, Thailand and Vietnam were previously affected by widespread H5N1 outbreaks in

poultry during early 2004. At that time, more than 100 million birds either died from the disease or were culled (killed) in efforts to

contain the outbreaks. Human cases (34 in all) were reported only in Thailand and Vietnam. The last case officially confirmed and

reported to the WHO by Vietnam occurred in February 2004.

Beginning in late June 2004, however, new lethal outbreaks of highly pathogenic avian influenza A (H5N1) among poultry were reported to

the World Organization for Animal Health (OIE) by China, Indonesia, Thailand and Vietnam. The deaths reported by Vietnam on August 12 are

the first reported human cases associated with this second wave of H5N1 infection among poultry. CDC is in communication with WHO and

will continue to monitor the situation.

Enhanced U.S. Surveillance, Diagnostic Evaluation and Infection Control Precautions for Avian Influenza A (H5N1)

CDC recommends maintaining the enhanced surveillance efforts by state and local health departments, hospitals and clinicians to identify

patients at increased risk for avian influenza A (H5N1) that were issued by CDC on February 3, 2004 (see:

http://www.cdc.gov/flu/han020302.htm ). Guidelines for enhanced surveillance are:

Testing for avian influenza A (H5N1) is indicated for hospitalized patients with:

1. Radiographically confirmed pneumonia, acute respiratory distress syndrome (ARDS) or other severe respiratory illness for which analternate diagnosis has not been established AND
2. History of travel within 10 days of symptom onset to a country with documented H5N1 avian influenza in poultry and/or humans (for aregularly updated listing of H5N1-affected countries, see the OIE Web site at: http://www.oie.int/eng/en_index.htm  and the WHO Web site at:  http://www.who.int/en/).

Testing for avian influenza A (H5N1) should be considered on a case-by-case basis in consultation with state and local health departments

for hospitalized or ambulatory patients with:

1. Documented temperature of >38°C (>100.4°F) AND
2. One or more of the following: cough, sore throat, shortness of breath AND
3. History of contact with poultry (e.g., visited a poultry farm, a household raising poultry or a bird market) or a known or suspectedhuman case of influenza A (H5N1) in an H5N1-affected country within 10 days of symptom onset.

Infection control precautions for H5N1 remain unchanged from the CDC interim recommendations published on February 3, 2004

(see:  http://www.cdc.gov/flu/han020302.htm). These recommendations are further described in the CDC guidance document,

“Interim Recommendations for Infection Control in Health-Care Facilities Caring for Patients with Known or Suspected Avian

Influenza”  (see: http://www.cdc.gov/flu/avian/professional/infect-control.htm).

Laboratory Testing Procedures

Highly pathogenic avian influenza A (H5N1) is classified as a select agent and must be worked with under Biosafety Level (BSL) 3+

laboratory conditions. This includes controlled access double door entry with change room and shower, use of respirators, decontamination

of all wastes and showering out of all personnel. Laboratories working on these viruses must be certified by the U.S. Department of

Agriculture. CDC does not recommend that virus isolation studies on respiratory specimens from patients who meet the above criteria be

conducted unless stringent BSL 3+ conditions can be met. Therefore, respiratory virus cultures should not be performed in most clinical

laboratories and such cultures should not be ordered for patients suspected of having H5N1 infection.

Clinical specimens from suspect A (H5N1) cases may be tested by PCR assays using standard BSL 2 work practices in a Class II biological

safety cabinet. In addition, commercial antigen detection testing can be conducted under BSL 2 levels to test for influenza.

Specimens from persons meeting the above clinical and epidemiologic criteria should be sent to CDC if:

• The specimen tests positive for influenza A by PCR or by antigen detection testing OR
• PCR assays for influenza are not available at the state public health laboratory.

Because the sensitivity of commercially available rapid diagnostic tests for influenza may not always be optimal, CDC also will accept

specimens from persons meeting the above clinical criteria even if they test negative by influenza rapid diagnostic testing if PCR assays

are not available at the state laboratory.

Requests for testing should come through the state and local health departments, which should contact (404) 639-3747 or (404) 639-3591

and ask for the epidemiologist on call before sending specimens for influenza A (H5N1) testing.

Additional Avian Influenza A (H5N1) Information

• For information about reported outbreaks of avian influenza A (H5N1) among poultry, see the web site of the World Organization ofAnimal Health (OIE) at: http://www.oie.int/eng/AVIAN_INFLUENZA/home.htm
• For information about human H5N1 cases, see the WHO web site at: http://www.who.int/en/
• For clinical information about human H5N1 cases, see:  CDC Cases of influenza A (H5N1) – Thailand, 2004. MMWR 2004;53:100-103at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5305a2.htm OR

  Hien TT, Liem AT, Dung NT, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. New England Journal of Medicine 2004;350:1179-1188.

• For general information about influenza, see the CDC website at: http://www.cdc.gov/flu